Iranian Journal of Otorhinolaryngology

Iranian Journal of Otorhinolaryngology

Omega-3 Adjunctive Therapy in Idiopathic SSNHL: A Randomised, Triple-Blind, Placebo-Controlled Trial

Document Type : Original

Authors
Benyamin Rahmaty 1
Kayvan Aghazadeh 1
Sasan Dabiri Satri 1
Masoud Motassadi Zarandi 1
Ali Kouhi 1
Nasrin Yazdani 1
Reza Erfanian 1
Ardavan Tajdini 1
Saeed Sohrabpour 1
Fatemeh Safi 2
Reza Shamsa 1
Hamideh Ravand 1
Neda Jafari 2
1 Otorhinolaryngologist-Head and Neck Surgeon, Otorhinolaryngology Research Center, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran.
2 Department of Radiology, Arak University of Medical Sciences, Arak, Iran.
10.22038/ijorl.2023.71955.3444
Abstract
Introduction:
Idiopathic Sudden Sensorineural Hearing Loss as a subset of sensorineural hearing loss will be confirmed by a progressive hearing loss of at least 30 dB at three contiguous frequencies over 72 hours or less. A sudden or abrupt hearing loss correlates with the time course, and a vascular event is presumptive aetiology. There is an inverse association between Omega-3 consumption and hearing loss. This study aimed to evaluate the efficacy of Omega-3 adjunctive therapy in Idiopathic Sudden Sensorineural Hearing Loss by audiometric assessments.
Materials and Methods:
In this randomised, triple-blind, placebo-controlled trial, all participants aged 18-70 with a history of sudden deafness (within 12 hours and ≤ 30 days) were eligible for enrollment. They were included if audiology diagnostic tests confirmed the SSNHL. Ultimately, they were randomised to the Omega-3 group and the placebo group.
Results:
Thirty-three patients were randomly allocated to the Omega-3 group and thirty-two to the placebo group. Vertigo (32.3% of all patients) and underlying conditions had significant relationships with complete response (C.R.)-final hearing level ≤of 25 dB in pure-tone average (P < 0.05). There was no significant difference between both groups before and after treatment. Although it was not statistically significant, patients in the Omega-3 group had faster recovery than placebo.
Conclusions:
Omega-3 adjunctive therapy did not have a therapeutic effect on SSNHL patients. Moreover, C.R. happened in half the patients. Vertigo and underlying conditions considerably worsen the recovery from SSNHL.
Keywords
Omega-3
Sudden sensorineural hearing loss (SSNHL)
Vertigo
Subjects
  1. H. Alexander Arts MEA. Sensorineural Hearing Loss in Adults. In: Flint PW, editor. Cummings Otolaryngology-Head and Neck Surgery. 3. 7th ed. Philadelphia: Elsevier; 2020. p. 2311.
  2. (NIDCD) NIoDaOCD. Sudden Deafness: U.S. Department of Health & Human Services; 2018 [Available from: https://www. nidcd.nih.gov/ health/ sudden-deafness.
  3. Mattox DE, Lyles CA. Idiopathic sudden sensorineural hearing loss. Am J Otol. 1989;10(3):242-7.
  4. Neeraj N Mathur MMC, Michele M Carr, Francisco Talavera, Peter S Roland, Arlen D Meyers, Sudden Hearing Loss2019. Available from: https:// emedicine. medscape.com/article/856313-overview#a5.
  5. Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, Moore HJ, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev [Internet]. 2012 2012/05//; (5):[CD002137 p.]. Available from: http:// europepmc. org/abstract/MED/22592684

https: // doi.org/10.1002/14651858.CD002137.pub3

https://europepmc.org/articles/PMC6486029https://europepmc.org/articles/PMC6486029?pdf=render.

  1. Gopinath B, Flood VM, Rochtchina E, McMahon CM, Mitchell P. Consumption of omega-3 fatty acids and fish and risk of age-related hearing loss. The American Journal of Clinical Nutrition. 2010;92(2):416-21.
  2. Schulz KF, Altman DG, Moher D, the CG. CONSORT 2010 Statement: updated guidelines for parallel reporting group randomised trials. BMC Medicine. 2010;8(1):18.
  3. Cheng YF, Chu YC, Tu TY, Shiao AS, Wu SL, Liao WH. Modified Siegel's sudden sensorineural hearing loss criteria: Reporting recovery outcomes with matched pretreatment hearing grades. Journal of the Chinese Medical Association: JCMA. 2018; 81(11):1008-12.
  4. Gurgel RK, Jackler RK, Dobie RA, Popelka GR. A New Standardized Format for Reporting Hearing Outcome in Clinical Trials. 2012;147(5):803-7.
  5. Brownson RJ, Zollinger WK, Madeira T, Fell D. Sudden sensorineural hearing loss following cervical spine manipulation. 1986;96(2):166-70.
  6. Ciccone MM, Scicchitano P, Gesualdo M, Cortese F, Zito A, Manca F, et al. Idiopathic sudden sensorineural hearing loss and ménière syndrome: The role of cerebral venous drainage. 2018; 43(1): 230-9.
  7. Chang C-F, Kuo Y-L, Chen S-P, Wang M-C, Liao W-H, Tu T-Y, et al. Relationship between idiopathic sudden sensorineural hearing loss and subsequent stroke. 2013;123(4):1011-5.
  8. Choung Y-H, Park K, Shin YR, Cho MJ. Intratympanic Dexamethasone Injection for Refractory Sudden Sensorineural Hearing Loss. 2006; 116(5):747-52.
  9. Jung DJ, Park JH, Jang JH, Lee K-Y. The efficacy of combination therapy for idiopathic sudden sensorineural hearing loss. 2016; 126(8): 1871-6.
  10. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495-505.
  11. Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017;18(1):19.
  12. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review.Atherosclerosis.2006;189(1):19-30.
  13. Musa-Veloso K, Binns MA, Kocenas AC, Poon T, Elliot JA, Rice H, et al. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. 2010;68(3):155-67.
  14. Martin JM, Stapleton RD. Omega-3 fatty acids in critical illness. 2010;68(9):531-41.
  15. Xie Y, Orabi NA, Zwolan TA, Basura GJ. Outcomes of unilateral idiopathic sudden sensorineural hearing loss: Two decades of experience. 2019;4(6):693-702.
  16. Shimanuki MN, Shinden S, Oishi N, Suzuki N, Iwabu K, Kitama T, et al. Early hearing improvement predicts the prognosis of idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology. 2021.
  17. Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden Sensorineural Hearing Loss: A Review of Diagnosis, Treatment, and Prognosis. 2011; 15(3): 91-105.
  18. Michos ED, McEvoy JW, Blumenthal RS. Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease. 2019;381(16):1557-67.
  19. Aung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, et al. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. JAMA Cardiology. 2018; 3(3): 225-33.
  20. Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. The Cochrane database of systematic reviews. 2018;11(11):Cd003177.
  21. Partearroyo T, Vallecillo N, Pajares MA, Varela-Moreiras G, Varela-Nieto I. Cochlear Homocysteine Metabolism at the Crossroad of Nutrition and Sensorineural Hearing Loss. 2017;10(107).
  22. Lasisi AO, Fehintola FA, Yusuf OB. Age-related hearing loss, vitamin B12, and folate in the elderly. Otolaryngology-Head and Neck Surgery. 2010; 143(6): 826-30.
Iranian Journal of Otorhinolaryngology
Volume 35, Issue 6
November and December 2023
Pages 311-319